Member Info for Prion25

AVA6000 peer reviewed by L Cranmer MD, PhD, FACP, Curtis and Elizabeth Anderson Endowed Professor in Sarcoma Research, University of Washington and Professor and Director of Sarcoma Oncology, Fred Hutchinson Cancer Center,

AVA6000 and ESMO Solid tumour data has been peer reviewed the latter by Prof Twelves

Asked Co pilot AI to do my sums

I have 60000 I shares in Haemogenyx and it has announced a share consolidation of 1 share for 400 the current SP is 1.28 pence what will be the likely share price after consolidation and the value of my shares?

Let's break this down:

1. Share Consolidation: Haemogenyx is consolidating its shares at a ratio of 1 new share for every 400 existing shares.

2. Current Share Price: The current share price is 1.28 pence.

To find the new share price after consolidation, you multiply the current share price by the consolidation ratio:

New Share Price=Current Share Price×Consolidation Ratio\{New Share Price} = \text{Current Share Price} \times \text{Consolidation Ratio}

New Share Price=1.28 pence×400=512 pence\text{New Share Price} = 1.28 \text{ pence} \times 400 = 512 \text{ pence}

So, the new share price will be 512 pence (or £5.12).

Next, let's determine the new number of shares you will hold:

New Number of Shares=Current Number of SharesConsolidation Ratio\text{New Number of Shares} = \frac{\text{Current Number of Shares}}{\text{Consolidation Ratio}}

New Number of Shares=60,000400=150\text{New Number of Shares} = \frac{60,000}{400} = 150

You will have 150 shares after the consolidation.

Finally, let's calculate the total value of your shares after consolidation:

Total Value=New Number of Shares×New Share Price\text{Total Value} = \text{New Number of Shares} \times \text{New Share Price}

Total Value=150×512 pence=76,800 pence\text{Total Value} = 150 \times 512 \text{ pence} = 76,800 \text{ pence}

Converting pence to pounds:

Total Value=76,800 pence100=£768\text{Total Value} = \frac{76,800 \text{ pence}}{100} = £768

So, the total value of your shares after consolidation will be £768.

Message Copilot

I believe this is good news for Ceres ,Only this morning BBC 24 hr News a reporter talking about the lack of capacity in energy in the context of the demand of clean energy for AI and data centres The only worry can Ed Millivolt see a great opportunity for UK tech and green jobs or is he all wind and carbon capture

Dug

I would not underestimate a poster presentation from my experience provided they have a good visual impact They will attract researchers with a specific interest on a one to one basis providing important feedback which can lead to collaborations with shared research findings .I am sure there will be a buzz around the poster and the scientist disseminating the ground breaking tech GLA

Https://www.bbc.co.uk/news/articles/cgmvx3jkmm3o

Certainly rings true in some Pharma companies I have been invested in ,what worries me is when big pharma might use their wealth to destroy up and coming small biotech companies by short selling etc and obtaining the companies on the cheap leaving share holders shirtless .Despicable activities especially when it involved cancer drugs .I suppose on Aim we have dodgy directors and CEOs wrecking good science

Will the Franchise system partnerships cover the costs ?

Reeves in HC live mentions data centres and AI several times Is there something in it for us or the SP telling us something different?

On million sell (or buy ?) at close !

Avacta however great the break through science it was a the lack of AI in the drug development was a worrying concern Now we have got it and its only will to add great value and exceptional data quickly and our competitors BP must be looking on !

Tempus AI in drug development is the sound bite

@Alpha-dog

Thanks for the response very much appreciated

Summary

Goggle & Amazon are investing in SMRs small modular nuclear reactors to power their AI data centres

Https://www.ft.com/content/33eeadbe-edf4-40b5-b973-e76c570d0681

I thought this would have been ideal niche for SOFC tech

* safe

AVA uses an approved drug and a delivery system that reduces toxicity and Osage surely. this could be used on compassionate grounds to treat this poor woman at very little cost

Hardly a vote of no confidence ?

Ask Sir Stephen " we know it works " Holgate by the way where is he ?

SOG

"Psoriasis is a long term treatment and in this instance long term treatment with such an inhibitor needs to clarify if there are likely problems to arise in sustained long term use"

I understand its a treatment not a cure but how long would you expect long term would be a life time or more than a year are there any examples with other treatments

thanks

.